Brayden Kameg
Psychiatric/Mental Health · Bridgeville, PANPI 1508418450
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $7,375 of the $11,121 with a category attached, or 66.3%. 17 manufacturers reported payments, led by Bausch Health US, LLC at 43.3% of the total. Reporting peaked in 2023 at $7,650 and has fallen 91.4% since, to $660 in 2025. Among psychiatric/mental health clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 322 payments — averaging $34.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bausch Health US, LLC$5K
- AbbVie$4K
- Supernus Pharmaceuticals, Inc.$592
- Takeda Pharmaceuticals U.S.A., Inc.$438
- Lundbeck LLC$222
- Axsome Therapeutics, Inc.$194
- plus $569 from 11 others
What the payments were for
- Consulting fees$7,37566%
- Food & beverage$3,74634%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bausch Health US, LLC | 69 | $4,810 |
| AbbVie | 80 | $4,295 |
| Supernus Pharmaceuticals, Inc. | 66 | $592 |
| Takeda Pharmaceuticals U.S.A., Inc. | 54 | $438 |
| Lundbeck LLC | 27 | $222 |
| Axsome Therapeutics, Inc. | 13 | $194 |
| Inspire Medical Systems, Inc. | 1 | $119 |
| Daiichi Sankyo Inc. | 1 | $103 |
| Alnylam Pharmaceuticals Inc. | 1 | $101 |
| Novo Nordisk | 1 | $86 |
| Almatica Pharma LLC | 3 | $59 |
| Neurocrine Biosciences, Inc. | 1 | $29 |
| Johnson & Johnson | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Astellas Pharma US Inc | 1 | $14 |
| Aytu Biopharma, Inc. | 1 | $13 |
| Neos Therapeutics, LP | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- APLENZIN$4,125
- Inspire$119
- Auvelity$114
- INJECTAFER$103
- ONPATTRO$101
How this compares
$11,121 in reported general payments places this provider in the 95th percentile of 1,041 psychiatric/mental health providers in Pennsylvania.
See all psychiatric/mental health providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aripiprazole | 21 | $1,929 |
| Mirtazapine | 55 | $964 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 21 | $860 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 51 | $735 |
| Atomoxetine Hcl | 11 | $729 |
| Bupropion XlBupropion Hcl | 71 | $648 |
| Sertraline Hcl | 58 | $471 |
| Quetiapine Fumarate | 36 | $431 |
| Fluoxetine Hcl | 40 | $429 |
| Prazosin Hcl | 48 | $372 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 25 | $313 |
| Lamotrigine | 40 | $276 |
| Escitalopram Oxalate | 29 | $258 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 46 | $255 |
| Clonazepam | 68 | $237 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Almatica Pharma LLCSertraline Hcl | $59 | $47158 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,041 psychiatric/mental health providers in Pennsylvania.
Other psychiatric/mental health in Bridgeville
- Samantha PavlickBridgeville$7K
- Kimberly GarciaAllentown$573K
- Cortney SmithWashington$227K
- Britney KeplerPittsburgh$158K
- Kirstyn KamegBethel Park$136K
- Anna DipietroDowningtown$131K
- Deena MasciocchiLanghorne$71K
- Joseph GagnonChesterbrook$64K
- Michelle CohenWashington$62K
- Sharon KatzJenkintown$51K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.